Sign Up to like & get
recommendations!
1
Published in 2023 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2023.2181794
Abstract: ABSTRACT Introduction The treatment paradigm for chronic rhinosinusitis with nasal polyps (CRSwNP) is complex, consisting of a combination of conservative, medical and surgical management. High rates of recurrence despite current standard of care has led…
read more here.
Keywords:
nasal polyps;
mepolizumab treatment;
chronic rhinosinusitis;
rhinosinusitis nasal ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Thorax"
DOI: 10.1136/thorax-2018-212555.87
Abstract: Introduction and objectives Anti IL-5 agents are used in addition to routine therapies: inhaled corticosteroids (ICS), long acting beta2-agonists (LABA), long acting muscarinic antagonists (LAMA), Leukotriene Receptor Antagonists (LRTA), and short acting beta2-agonists (SABA), in…
read more here.
Keywords:
initiation mepolizumab;
ocs;
initiation;
mepolizumab treatment ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1183156
Abstract: Oral corticosteroids (OCS) are commonly used for the acute management of severe asthma exacerbations or as maintenance therapy; however, chronic use is associated with significant toxicities, e.g., osteoporosis. In the REal worlD Effectiveness and Safety…
read more here.
Keywords:
potential impact;
mepolizumab;
dependent asthma;
mepolizumab treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Turkish Journal of Medical Sciences"
DOI: 10.3906/sag-1912-62
Abstract: Background/aim Oral corticosteroid (OCS)-dependent severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps (SEA-CRSwNP) would be a suitable phenotype for mepolizumab treatment. This study evaluated the short-term efficacy of mepolizumab treatment in OCS-dependent SEA-CRSwNP. Materials…
read more here.
Keywords:
efficacy mepolizumab;
week;
treatment;
study ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Turkish Thoracic Journal"
DOI: 10.5152/turkthoracj.2022.22023
Abstract: OBJECTIVE: Anecdotal reports among clinicians treating severe asthma patients with novel add-on treatments such as mepolizumab suggest that a fraction of these patients may experience a much more dramatic benefit from these agents than reported…
read more here.
Keywords:
treatment;
severe asthma;
mepolizumab treatment;
super responders ... See more keywords